Toronto Dominion Bank Buys 82,597 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)
Toronto Dominion Bank increased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 53.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 237,922 shares of the pharmacy operator’s stock after buying an additional 82,597 shares during the period. Toronto Dominion Bank’s holdings in Walgreens Boots Alliance were worth $19,759,000 as of its most recent SEC filing.
Other institutional investors also recently made changes to their positions in the company. Glassman Wealth Services increased its position in shares of Walgreens Boots Alliance by 0.6% in the fourth quarter. Glassman Wealth Services now owns 2,898 shares of the pharmacy operator’s stock worth $240,000 after buying an additional 18 shares in the last quarter. Moloney Securities Asset Management LLC bought a new position in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $566,000. Intellectus Partners LLC acquired a new position in shares of Walgreens Boots Alliance during the fourth quarter worth about $548,000. First Republic Investment Management Inc. increased its position in shares of Walgreens Boots Alliance by 2.1% in the fourth quarter. First Republic Investment Management Inc. now owns 198,960 shares of the pharmacy operator’s stock worth $16,466,000 after buying an additional 4,130 shares during the period. Finally, GSA Capital Partners LLP increased its position in shares of Walgreens Boots Alliance by 754.5% in the fourth quarter. GSA Capital Partners LLP now owns 37,873 shares of the pharmacy operator’s stock worth $3,134,000 after buying an additional 33,441 shares during the period. 61.17% of the stock is owned by institutional investors and hedge funds.
Walgreens Boots Alliance, Inc. (WBA) traded down 0.53% during midday trading on Tuesday, hitting $81.08. The stock had a trading volume of 4,036,340 shares. The stock has a 50-day moving average price of $78.70 and a 200 day moving average price of $82.37. Walgreens Boots Alliance, Inc. has a one year low of $75.18 and a one year high of $89.69. The firm has a market cap of $86.76 billion, a PE ratio of 20.47 and a beta of 1.25.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share for the quarter, beating the consensus estimate of $1.30 by $0.03. The firm had revenue of $30.12 billion for the quarter, compared to the consensus estimate of $29.72 billion. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The firm’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.18 EPS. On average, analysts predict that Walgreens Boots Alliance, Inc. will post $5.01 earnings per share for the current year.
Walgreens Boots Alliance announced that its board has approved a share buyback program on Thursday, June 29th that permits the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to reacquire up to 5.9% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company’s board believes its shares are undervalued.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th will be paid a dividend of $0.40 per share. The ex-dividend date is Wednesday, August 16th. This represents a $1.60 annualized dividend and a yield of 1.97%. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s payout ratio is presently 37.78%.
TRADEMARK VIOLATION NOTICE: “Toronto Dominion Bank Buys 82,597 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/08/08/toronto-dominion-bank-raises-stake-in-walgreens-boots-alliance-inc-nasdaqwba-updated-updated-updated.html.
WBA has been the subject of a number of research analyst reports. Credit Suisse Group reaffirmed a “buy” rating and issued a $97.00 price target on shares of Walgreens Boots Alliance in a report on Thursday, July 13th. Leerink Swann set a $86.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Friday, July 7th. Citigroup Inc. reaffirmed a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Guggenheim reaffirmed a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Finally, Needham & Company LLC raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $94.00 price target for the company in a report on Friday, June 30th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $90.69.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total transaction of $218,305.44. Following the sale, the director now owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 13.50% of the stock is owned by insiders.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.